Medicago Revenue and Competitors
Estimated Revenue & Valuation
- Medicago's estimated annual revenue is currently $35.3M per year.
Employee Data
Medicago's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Human Resources Officer | Reveal Email/Phone |
2 | Associate Director Maintenance | Reveal Email/Phone |
3 | Director Regulatory Affairs Strategy | Reveal Email/Phone |
4 | Manager, Legal Affairs | Reveal Email/Phone |
5 | Manager Engineering | Reveal Email/Phone |
6 | Infrastructure Manager | Reveal Email/Phone |
7 | System Administrator II | Reveal Email/Phone |
8 | Senior Clinical Global Supply Planner | Reveal Email/Phone |
9 | Senior QC Specialist | Reveal Email/Phone |
10 | QC Specialist III | Reveal Email/Phone |
Medicago Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1200M | 1330 | -6% | $2.4B | $8.4B |
#2 | $11830M | 8030 | 26% | $2.7B | $83B |
#3 | $69340M | 107310 | 4% | N/A | $308.4B |
#4 | $32820M | 83449 | 7% | N/A | $182.4B |
#5 | $141.7M | 308 | 1% | N/A | N/A |
What Is Medicago?
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based manufacturing and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges. The story of Medicago is rooted in a long track record of innovation and perseverance. Even our company name the Latin word for alfalfa, which was the first plant we worked with embodies our culture of adaptation. We're proud of our humble beginnings as much as we are of our current growth and global reach. We understand better than most that the path to success in not a straight line. As a pioneer of plant-based transient expression and manufacturing, Medicago has always sought a more effective way to improve human health. With nearly 20 years of experience and wisdom behind us, we are ready to disrupt the traditional approach to vaccines and therapeutics.
keywords:Biotechnology,E-Commerce,Healthcare,Pharmaceuticals
N/A
Total Funding
N/A
Number of Employees
$35.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Medicago News
... preferable to the Canadian-made Medicago vaccine in most circumstances. Health Canada authorized the Medicago vaccine in February for...
The Quebec Immunization Committee recommends the use of mRNA vaccines over Medicago. CBC News · Posted: Apr 20, 2022 6:08 AM ET | Last Updated:...
Quebec's immunization committee issued its guidance Tuesday on Medicago's Covifenz vaccine, saying established mRNA vaccines such as those...
Nicotiana benthamiana. A Japanese drugmaker plans to submit data for a plant-based Covid-19 vaccine to Canadian regulators. The vaccine is made using a relative of the tobacco plant. Medicago, which is making the vaccine, is part-owned by tobacco giant Philip Morris International. For more stor ...
Mitsubishi Tanabe will fund R&D costs and Medicago will license rights to its vaccine technology to the pharma company. If Mitsubishi Tanabe exercises its option to license vaccines developed from the partnership, the Japanese pharma will take on responsibility for global development, regulatory ...